Opportunity Information: Apply for PAR 06 476
Apply for PAR 06 476
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and Women and Sex/Gender Differences (R36)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Jul 10, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education.
- Foreign institutions are not eligible to apply. A doctoral candidate may submit only one application in response to this announcement. Projects funded through the NIH Dissertation Award mechanism must support research activities related to preparation of a dissertation.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Drug Abuse Dissertation Research: Epidemiology, Prevention, Treatment, Services, and Women and Sex/Gender Differences (R36) opportunity (Funding Opportunity Number PAR-06-476) is a National Institutes of Health (NIH) grant program designed specifically to support doctoral students who are conducting dissertation research focused on drug abuse and addiction. The central goal of the announcement is to provide targeted, dissertation-stage funding for studies that advance knowledge in key public health and clinical areas tied to substance use, including the patterns and determinants of drug use (epidemiology), strategies to stop drug use before it starts or escalates (prevention), approaches to reduce use and improve recovery outcomes (treatment), the systems and programs that deliver care and supports (services research), and research that addresses women and sex/gender differences. In other words, it is meant to help doctoral candidates complete a rigorous, clearly defined research project that directly supports the production of their dissertation while contributing useful evidence to the drug abuse field.
This funding is offered through the NIH Dissertation Award (R36) mechanism, which is an NIH grant type structured to support dissertation research activities. The program falls under the broader federal assistance listing for Drug Abuse and Addiction Research Programs (CFDA 93.279) and is categorized as a discretionary grant in the health and education activity space. The intended applicants are higher education institutions (both public/state-controlled and private institutions of higher education), reflecting the fact that NIH training and dissertation awards are typically submitted through the student’s university rather than by the student as an independent organization. Importantly, foreign institutions are not eligible to apply under this announcement, so the sponsoring institution must be based in the United States.
In terms of funding levels and duration, awards under this FOA provide up to $50,000 per year in direct costs, and the project period can be up to two years. The announcement also notes that an extension of up to 12 months may be possible, but only as a no-cost extension, meaning it would allow more time to finish the approved scope of work without providing additional money. Because dissertation projects can vary widely in scope, methods, and resource needs, the FOA anticipates that individual award sizes and durations may differ from one application to another, as long as they stay within the stated cap. The program does not require cost sharing or matching funds, which reduces barriers for students and institutions that might not have discretionary resources to contribute.
Eligibility is narrowly framed around the dissertation purpose and the doctoral trainee status. Projects supported through the R36 mechanism must be clearly tied to the preparation of a dissertation, rather than serving as general lab funding or a broader research program. The FOA also specifies an important limit: a doctoral candidate may submit only one application in response to this announcement, which underscores that this is meant to be a single, focused dissertation award rather than a repeatable funding stream for the same student.
Administratively, the opportunity was posted July 10, 2006, and lists multiple receipt dates rather than a single deadline, meaning applications were accepted on several scheduled submission cycles (with details provided in the full announcement). The record indicates an archive date of October 2, 2009, which suggests the original FOA is no longer active in that exact form, but the summary still reflects how NIH structured this particular dissertation support mechanism at the time. For applicants looking for the authoritative requirements, submission instructions, and receipt date schedule, the FOA directs readers to the full announcement hosted by NIH at: http://grants.nih.gov/grants/guide/pa-files/PAR-06-476.html. If there are access or linking issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, this R36 announcement is best understood as a dissertation-completion style grant for doctoral candidates whose research addresses drug abuse and addiction through epidemiological, preventive, treatment, or services lenses, with explicit encouragement for work that examines women and sex/gender differences. The practical value of the award is that it can pay for essential research costs during a critical period of doctoral training, helping students complete a high-quality dissertation project that aligns with NIH priorities in substance use research.
Frequently Asked Questions (FAQs)
What is the Drug Abuse Dissertation Research (R36) opportunity?
It is an NIH grant program (Dissertation Award, R36) intended to support doctoral students conducting dissertation research focused on drug abuse and addiction. The opportunity is identified as Funding Opportunity Number (FON) PAR-06-476.
What is the main purpose of this funding opportunity?
The central goal is to provide targeted, dissertation-stage support for a clearly defined research project that directly contributes to a doctoral dissertation while advancing knowledge in drug abuse and addiction-related public health and clinical areas.
What research areas does this FOA emphasize?
The announcement highlights dissertation research in:
- Epidemiology (patterns and determinants of drug use)
- Prevention (strategies to stop drug use before it starts or escalates)
- Treatment (approaches to reduce use and improve recovery outcomes)
- Services research (systems and programs that deliver care and supports)
- Women and sex/gender differences related to drug abuse and addiction
Who is this grant designed to support?
It is designed specifically for doctoral students who are conducting dissertation research in the drug abuse and addiction field. The project must be clearly tied to dissertation preparation.
Who submits the application: the student or the university?
The intended applicants are higher education institutions (public/state-controlled and private institutions of higher education). This reflects that NIH dissertation awards are typically submitted through the student’s university rather than by the student as an independent entity.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible under this announcement. The sponsoring/applicant institution must be based in the United States.
How much funding is available per award?
Awards provide up to $50,000 per year in direct costs.
How long can the project period be?
The project period can be up to two years.
Is it possible to extend the project period?
An extension of up to 12 months may be possible as a no-cost extension, meaning extra time may be allowed to complete the approved work without additional funding.
Are all awards the same size and duration?
Not necessarily. The FOA anticipates that award sizes and durations may vary across applications, as long as they remain within the stated funding cap and time limits.
Is cost sharing or matching required?
No. The program does not require cost sharing or matching funds.
What is the key eligibility requirement related to the project itself?
The project must be clearly tied to preparation of a dissertation. It is not intended to function as general laboratory support or broader program funding outside the dissertation scope.
How many applications can a doctoral candidate submit to this announcement?
The FOA specifies that a doctoral candidate may submit only one application in response to this announcement.
What is the CFDA (assistance listing) associated with this program?
The program falls under Drug Abuse and Addiction Research Programs, CFDA 93.279.
What type of grant is this considered?
It is described as a discretionary grant in the health and education activity space, using the NIH Dissertation Award (R36) mechanism.
When was this opportunity posted?
The opportunity was posted on July 10, 2006.
Is there a single application deadline?
No. The announcement lists multiple receipt dates rather than one deadline, meaning applications were accepted during several scheduled submission cycles (with details available in the full FOA).
Is this funding opportunity still active?
The record indicates an archive date of October 2, 2009, which suggests the original FOA is no longer active in that exact form.
Where can applicants find the full announcement and official requirements?
The FOA directs readers to the full NIH announcement at: http://grants.nih.gov/grants/guide/pa-files/PAR-06-476.html.
Who is the contact if there are access or linking issues with the FOA?
The contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What is the practical value of this award for doctoral students?
It can pay for essential dissertation research costs during a critical stage of doctoral training, helping students complete a rigorous dissertation project that aligns with NIH priorities in substance use research.
Browse more business programs for Women in Business, Drug Abuse Research and Prevention
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Research Opportunities in Stuttering (R21)
Previous opportunity: The Role of Nuclear Receptors in Tissue and Organismal Aging (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 06 476
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 06 476) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral and Integrative Treatment Development Program (R21) Apply for PA 06 487 Funding Number: PA 06 487 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Behavioral and Integrative Treatment Development Program (R03) Apply for PA 06 488 Funding Number: PA 06 488 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R21) Apply for PA 06 496 Funding Number: PA 06 496 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R03) Apply for PA 06 497 Funding Number: PA 06 497 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis(R21) Apply for PA 06 499 Funding Number: PA 06 499 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R03) Apply for PA 06 502 Funding Number: PA 06 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R21) Apply for PA 06 501 Funding Number: PA 06 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cancer Institute (NCI) Cancer Education and Career Development Program (R25) Apply for PAR 06 511 Funding Number: PAR 06 511 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 06 461 Funding Number: PA 06 461 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R33) Apply for PA 06 462 Funding Number: PA 06 462 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award R21/R33) Apply for PA 06 463 Funding Number: PA 06 463 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R03) Apply for PAR 06 520 Funding Number: PAR 06 520 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Dissemination and Implementation Research in Health (R21) Apply for PAR 06 521 Funding Number: PAR 06 521 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Translational Research for the Prevention and Control of Diabetes and Obesity (R18) Apply for PAR 06 532 Funding Number: PAR 06 532 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral Science Track Award for Rapid Transition (B/START) (R03) Apply for PAR 06 541 Funding Number: PAR 06 541 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Apply for PA 07 022 Funding Number: PA 07 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Focal Cognitive Deficits in CNS Disorders (R03) Apply for PA 07 034 Funding Number: PA 07 034 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Focal Cognitive Deficits in CNS Disorders (R21) Apply for PA 07 035 Funding Number: PA 07 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 07 049 Funding Number: PAR 07 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Molecular genetics of drug addiction and related co morbidities (R01) Apply for PA 07 073 Funding Number: PA 07 073 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 06 476", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.